NU Skin Enterprises, Inc. (NUS)
NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries · Wholesale trade · CIK 1021561 · fiscal year ends in Dec
Closing price $4.67 on 30 Oct 2026; 52-week range $4.52 to $11.54.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $1.4B
- Revenue growth
- -15.4%
- Net income, last twelve months
- -$216.4M
- Earnings per share
- -$4.47
- Gross margin
- 69.2%
- Operating margin
- -0.8%
- Net margin
- -15.7%
- Free cash flow
- $10.8M
- Return on equity
- -39.9%
- Market value
- $227.3M
- Cash
- $189.6M
- Debt
- $213.7M
- Debt to equity
- 0.39
- Shares outstanding
- 48.7M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $1.5B | $65.8M | $160.2M | $3.18 | $46.0M | 10-K filed 13 Feb 2026 |
| FY2024 | 31 Dec 2024 | $1.7B | -$151.6M | -$146.6M | -$2.95 | $70.2M | 10-K filed 14 Feb 2025 |
| FY2023 | 31 Dec 2023 | $2.0B | $48.3M | $8.6M | $0.17 | $60.1M | 10-K filed 15 Feb 2024 |
| FY2022 | 31 Dec 2022 | $2.2B | $110.8M | $104.8M | $2.07 | $49.0M | 10-K filed 16 Feb 2023 |
| FY2021 | 31 Dec 2021 | $2.7B | $234.0M | $147.3M | $2.86 | $73.0M | 10-K filed 16 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $320.1M | -$249.8M | -$5.14 |
| Q1 FY2026 | 31 Mar 2026 | $320.6M | $1.8M | $0.04 |
| Q4 FY2025 | 31 Dec 2025 | $370.3M | $14.5M | $0.29 |
| Q3 FY2025 | 30 Sep 2025 | $364.2M | $17.1M | $0.34 |
| Q2 FY2025 | 30 Jun 2025 | $386.1M | $21.1M | $0.43 |
| Q1 FY2025 | 31 Mar 2025 | $364.5M | $107.5M | $2.14 |
| Q4 FY2024 | 31 Dec 2024 | $445.6M | -$36.1M | -$0.73 |
| Q3 FY2024 | 30 Sep 2024 | $430.1M | $8.3M | $0.17 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By business, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Americas | $283.0M | 19.1% |
| Southeast Asia/Pacific | $209.8M | 14.1% |
| Manufacturing | $205.8M | 13.9% |
| Mainland China | $195.6M | 13.2% |
| Japan | $174.4M | 11.7% |
| Europe & Africa | $150.2M | 10.1% |
| South Korea | $130.2M | 8.8% |
| Hong Kong/Taiwan | $117.4M | 7.9% |
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Wellness | $689.1M | 46.4% |
| Beauty | $568.1M | 38.3% |
| Other | $228.0M | 15.4% |
Company events
The newest 8-K filings of 257 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 21 Aug 2026 | 8-K | Leadership change | 5.02 |
| 10 Aug 2026 | 8-K | Results | 2.02, 9.01 |
| 29 May 2026 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07, 9.01 |
| 8 May 2026 | 8-K | Leadership change | 5.02 |
| 7 May 2026 | 8-K | Results | 2.02, 9.01 |
| 27 Mar 2026 | 8-K | Material agreement, New debt | 1.01, 2.03, 9.01 |
| 20 Mar 2026 | 8-K | Leadership change | 5.02, 9.01 |
| 9 Mar 2026 | 8-K | Leadership change | 5.02, 9.01 |
| 12 Feb 2026 | 8-K | Results | 2.02, 9.01 |
| 6 Nov 2025 | 8-K | Results | 2.02, 9.01 |
| 7 Aug 2025 | 8-K | Results | 2.02, 9.01 |
| 30 May 2025 | 8-K | Leadership change, Shareholder vote | 5.02, 5.07, 9.01 |
Every filing
The newest filings with the SEC of 593 held.
| Filed | Form | Period |
|---|---|---|
| 21 Aug 2026 | 8-K | 17 Aug 2026 |
| 10 Aug 2026 | 10-Q | 30 Jun 2026 |
| 10 Aug 2026 | 8-K | 10 Aug 2026 |
| 1 Jun 2026 | S-8 | – |
| 29 May 2026 | 8-K | 28 May 2026 |
| 21 May 2026 | SD | – |
| 8 May 2026 | 8-K | 6 May 2026 |
| 8 May 2026 | 10-Q | 31 Mar 2026 |
| 7 May 2026 | 8-K | 7 May 2026 |
| 3 Apr 2026 | ARS | 31 Dec 2025 |
| 3 Apr 2026 | DEFA14A | – |
| 3 Apr 2026 | DEF 14A | 28 May 2026 |
Insider trades
Form 4 trades by officers, directors and 10% owners, last 12 months.
| Traded | Insider | Type | Shares | Price | Value | Held after | Form 4 |
|---|---|---|---|---|---|---|---|
| 2 Jun 2026 | Winett James M, Director | Sale under a trading plan | 7,203 | $5.62 | $40.5K | 37,448 | 3 Jun 2026 |
| 1 Jun 2026 | Woodbury Edwina D, Director | Sale under a trading plan | 7,203 | $5.70 | $41.1K | 62,433 | 3 Jun 2026 |
| 11 May 2026 | Nathanson Laura, Director | Sale outside a trading plan | 2,676 | $6.73 | $18.0K | 30,473 | 12 May 2026 |
| 11 Nov 2025 | Hatchett Steven Keith, Chief Product Officer | Purchase | 5,500 | $9.61 | $52.9K | 167,565 | 12 Nov 2025 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 2 Jun 2026 | Winett James M, Director | 7,203 | $40.5K | 2 Jun 2026 |
| 1 Jun 2026 | WOODBURY EDWINA D, Director | 7,203 | $41.1K | 1 Jun 2026 |
| 11 May 2026 | Nathanson Laura, Director | 2,676 | $19.2K | 11 May 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 14 May 2026 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13G amended | 4.45% | 0 |
| 27 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 12 Feb 2026 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 13G | 5.37% | 2.6M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 4.5M | -1.73% | 9.36 |
| 30 Sep 2026 | 4.6M | -3.15% | 8.48 |
| 15 Sep 2026 | 4.8M | +5.44% | 8.85 |
| 31 Aug 2026 | 4.5M | +1.79% | 9.36 |
| 14 Aug 2026 | 4.4M | -3.97% | 5.96 |
| 31 Jul 2026 | 4.6M | +10.52% | 10 |
| 15 Jul 2026 | 4.2M | +10.21% | 5.99 |
| 30 Jun 2026 | 3.8M | +5.21% | 3.53 |
Funds that hold it
From each fund's latest Form 13F.
201 funds held it at 30 Jun 2026: 75 added and 61 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 4,315,878 | $22.8M | +24,615 |
| American Century Companies Inc. | 2,301,308 | $12.2M | +280,106 |
| Coppell Advisory Solutions LLC | 235 | $11.3M | – |
| Vanguard Capital Management LLC | 2,049,641 | $10.8M | -13,709 |
| Acadian Asset Management LLC | 1,953,174 | $10.3M | +189,519 |
| Dimensional Fund Advisors LP | 1,796,745 | $9.5M | +61,563 |
| Prescott Group Capital Management, L.L.C. | 1,794,608 | $9.5M | 0 |
| Vanguard Portfolio Management LLC | 1,736,856 | $9.2M | +27,303 |
| Renaissance Technologies LLC | 1,607,692 | $8.5M | -92,804 |
| Charles Schwab Investment Management Inc. | 1,452,937 | $7.7M | -690,357 |
Peers
Companies in the same industry.
- McKesson Corp. (MCK): revenue $411.0B, market value $116.1B
- Cencora, Inc. (COR): revenue $332.8B, market value $63.2B
- Cardinal Health Inc. (CAH): revenue $254.2B, market value $58.3B
- Herbalife Ltd. (HLF): revenue $5.2B, market value $1.4B